{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:34:46Z","timestamp":1786649686037,"version":"build-2736575974"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012]]},"DOI":"10.4103\/0022-3859.105436","type":"journal-article","created":{"date-parts":[[2013,1,3]],"date-time":"2013-01-03T06:14:27Z","timestamp":1357193667000},"page":"233-234","source":"Crossref","is-referenced-by-count":0,"title":["CYP2B6"],"prefix":"10.4103","volume":"58","author":[{"given":"NJ","family":"Gogtay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20240205","doi-asserted-by":"crossref","first-page":"598","DOI":"10.2174\/138920008785821710","article-title":"CYP2B6: New insights into a historically overlooked Cytochrome P450 isoenzyme","volume":"9","author":"Wang","year":"2008","journal-title":"Curr Drug Metab"},{"key":"R2-1-20240205","first-page":"414","article-title":"Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians","volume":"270","author":"Shimada","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"R3-1-20240205","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1081\/DMR-100101942","article-title":"The role of CYP2B6 in xenobiotic metabolism","volume":"31","author":"Ekins","year":"1999","journal-title":"Drug Metab Rev"},{"key":"R4-1-20240205","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2174\/138920008784746346","article-title":"Molecular characterization of CYP2B6 substrates","volume":"9","author":"Ekins","year":"2008","journal-title":"Curr Drug Met"},{"key":"R5-1-20240205","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1002\/pros.20597","article-title":"Cytochrome P4502B6 is a growth inhibitory and prognostic factor for prostate cancer","volume":"67","author":"Kumagai","year":"2007","journal-title":"Prostate"},{"key":"R6-1-20240205","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2217\/14622416.8.7.743","article-title":"Polymorphic CYP2B6: Molecular mechanisms and emerging clinical significance","volume":"8","author":"Zanger","year":"2007","journal-title":"Pharmacogenomics"},{"key":"R7-1-20240205","doi-asserted-by":"crossref","first-page":"730","DOI":"10.2174\/138920009789895534","article-title":"Substrate specificity, regulation, and polymorphism of human cytochrome P450 2B6","volume":"10","author":"Mo","year":"2009","journal-title":"Curr Drug Metab"},{"key":"R9-1-20240205","doi-asserted-by":"crossref","first-page":"233","DOI":"10.4103\/0022-3859.105439","article-title":"Haplotype frequencies of CYP2B6 in Malaysia","volume":"58","author":"Musa","year":"2012","journal-title":"J Postgrad Med"},{"key":"R10-1-20240205","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1093\/jac\/dkr075","article-title":"Factors influencing plasma nevirapine levels: A study in HIV-infected children on generic antiretroviral treatment in India","volume":"66","author":"Swaminathan","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"R11-1-20240205","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/jac\/dkp033","article-title":"Association of high T allele frequency of CYP2B6 G516T polymorphism among ethnic south Indian HIV-infected patients with elevated plasma efavirenz and nevirapine","volume":"63","author":"Ramachandran","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"R12-1-20240205","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1128\/AAC.00899-08","article-title":"CYP2B6 G516T polymorphism but not rifampin coadministration influences steady-state pharmacokinetics of efavirenz in human immunodeficiency virus-infected patients in South India","volume":"53","author":"Ramachandran","year":"2009","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of Postgraduate Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00005257-201258040-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:57:03Z","timestamp":1786647423000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00005257-201258040-00001"}},"subtitle":["Inching towards personalized medicine"],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.4103\/0022-3859.105436","relation":{},"ISSN":["0022-3859"],"issn-type":[{"value":"0022-3859","type":"print"}],"subject":[],"published":{"date-parts":[[2012]]}}}